Dr. Palacios serves as the Chief Science Officer at Bright Therapeutics, developers of leading DTx products including Recovery Record for eating disorders, Recovery Path for substance use disorders and Moodlinks for behavioral health conditions. He drives clinical research, data analytics, and promotes the science of digital health across commercial, clinical, policy and academic landscapes. Prior to Bright, he played a pivotal role in advancing the research strategy at SilverCloud Health up to acquisition and integration into Amwell. A medical graduate from Mexico, he furthered his studies in London with postgraduate training in Psychiatric Research and earned a PhD from King’s College London’s Institute of Psychiatry, Psychology, and Neuroscience. His notable accolades include the Young Investigator of the Year award by the European Association of Psychological Medicine. Passionate about expanding access to digital health solutions globally, Dr. Palacios has been featured at numerous academic and non-academic international events and in top-tier academic journals. He loves to share insights from his research and underscore the need for collaborative approaches to enhance the reach of evidence-based digital interventions.